CMPX vs ROST · $367.4M cap vs P/E 21, rev $21.13B
Compass Therapeutics Inc. (CMPX) versus Ross Stores Inc (ROST) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
Ross Stores Inc (ROST) is a apparel retail company listed on US.
CMPX does not have a complete income-statement cache yet.
Latest reported ROST revenue for 2025-02-01 was $21.13B. Net income was $2.09B. Revenue was up 3.7% from 2024-02-03 to 2025-02-01. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
CMPX currently screens at market cap $367.4M. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
Not investment advice. Open the CMPX and ROST stock pages for the full models.
Not investment advice.